Literature DB >> 7200398

Synergistic effect of ricin in combination with daunorubicin, cis-dichlorodiammineplatinum(II) and vincristine in systemic L1210 leukemia.

O Fodstad, A Pihl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7200398

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 2.  Immunotoxin therapy of malignant melanoma.

Authors:  L E Spitler
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

3.  Pharmacological studies of ricin in mice and humans.

Authors:  A Godal; O Fodstad; K Ingebrigtsen; A Pihl
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

4.  Pharmacokinetics and toxicology of sparsomycin in beagle dogs.

Authors:  Z Zylicz; D J Wagener; P Fernandez del Moral; H van Rennes; J M Wessels; B Winograd; E van der Kleijn; T B Vree; U van Haelst; L A van den Broek
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 5.  Immunotoxin therapy for CNS tumor.

Authors:  Edward Rustamzadeh; Walter C Low; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

Review 6.  Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.

Authors:  Edward Rustamzadeh; Chunbin Li; Sekou Doumbia; Walter A Hall; Daniel A Vallera
Journal:  J Neurooncol       Date:  2003-10       Impact factor: 4.130
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.